chrisvoncsefalvay/vaers-outcomes huggingface dataset:
vaccine leaked out and ran down her arm. She does not think that she had full dose; vaccine leaked out and ran down her arm. She does not think that she had full dose; severe headache; fatigue; This is a spontaneous report received from a contactable consumer (patient). A 68-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL3247), via an unspecified route of administration in right arm on 20Jan2021 at 17:30 PM (at the age of 68-years-old) as a single dose for COVID-19 immunisation at hospital. The patient's medical history included asthma and breast cancer. Patient had allergies to latex, Penicillin, IVP dye, shellfish. The patient previously took codeine, mepivacaine hydrochloride (CARBOCAINE, dental anesthetic) and articaine hydrochloride, epinephrine bitartrate (SEPTOCAINE). Patient was not pregnant at the time of vaccination. Concomitant medications included anastrozole (ARIMIDEX), famotidine, ergocalciferol (VIT D), cetirizine hydrochloride (ZYRTEC) and AREDS2, all received in two weeks. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no COVID prior vaccination. On 20Jan2021, the patient experienced severe headache and fatigue for 7 days after though, which resulted in Doctor or other healthcare professional office/clinic visit. Patient reported that when vaccine was injected, she thought that vaccine leaked out and ran down her arm. She does not think that she had full dose. No treatment received for adverse events. On 28Jan2021, post vaccination, PCR test performed from nasal swab and received a negative result. On 04Feb2021, post vaccination, COVID test performed from saliva sample and received negative result. Outcome of the events headache and fatigue was recovered in 2021.  No follow-up attempts are possible. No further information is expected.
excessive redness , swelling and warmth noted from injection site in deltoid down to elbow Spouse received same vaccine and lot #  and had similar reaction.
Red knot at the site of injection; Red knot at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Red knot at the site of injection) and VACCINATION SITE ERYTHEMA (Red knot at the site of injection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MASS (Red knot at the site of injection) and VACCINATION SITE ERYTHEMA (Red knot at the site of injection). At the time of the report, VACCINATION SITE MASS (Red knot at the site of injection) and VACCINATION SITE ERYTHEMA (Red knot at the site of injection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications and treatment information were not provided.   Reporter did not allow further contact
got a Moderna shot and she could not use left arm later on.; This spontaneous case was reported by a consumer and describes the occurrence of HYPOKINESIA (got a Moderna shot and she could not use left arm later on.) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOKINESIA (got a Moderna shot and she could not use left arm later on.). At the time of the report, HYPOKINESIA (got a Moderna shot and she could not use left arm later on.) outcome was unknown.  The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.  Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2022: Live Follow up document attached.
Starting second day had terrible headache and chills, and mild nausea.  Headaches have never gone away , as I have had headaches every day that Tylenol, Excedrin will not touch.  I mentioned to my PCP last time I was there and again today when I went back for headaches.  He told me I need to report it .
I became flushed and it lasted a few days. it feels like a sunburn from the inside out and it was from the neck up. then I had a tingly tongue and a metallic taste in my mouth. it did NOT swell, it just didn't feel right. has resolved by today 03/23
Dizziness everytime I stood or walked, black vision with over exertion, shortness of breath, congestion, fainting spells, extremely high heart rate, brain fog, extreme fatigue
Body aches; face was swollen after receiving the second dose; did feel pain in  the injection site the day of the administration of the vaccine/pain in the arm; Chills; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (face was swollen after receiving the second dose), VACCINATION SITE PAIN (did feel pain in  the injection site the day of the administration of the vaccine/pain in the arm), MYALGIA (Body aches) and CHILLS (Chills) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032b21a) for COVID-19 vaccination.     Concurrent medical conditions included Anxiety. Concomitant products included ESCITALOPRAM for Anxiety.    On 19-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, the patient experienced VACCINATION SITE PAIN (did feel pain in  the injection site the day of the administration of the vaccine/pain in the arm) and CHILLS (Chills). On 14-Jul-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced SWELLING FACE (face was swollen after receiving the second dose). On an unknown date, the patient experienced MYALGIA (Body aches). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) on 20-Apr-2021 for Myalgia, at an unspecified dose and frequency. At the time of the report, SWELLING FACE (face was swollen after receiving the second dose) had not resolved and VACCINATION SITE PAIN (did feel pain in  the injection site the day of the administration of the vaccine/pain in the arm), MYALGIA (Body aches) and CHILLS (Chills) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 14-Aug-2021: Follow-up information received contains  - Events added  are pain in arm, chills and patient DOB corrected.
Pt reports swelling and erythema around lip and burning one hour after administration of vaccination with worsening redness and swelling to lips 3 hours after administration
Fevers 101F to 102F, severe rigors, diffuse myalgia, headaches leading to Emergency Dept visit at  Hospital Rideout on 12/24/2020
migraines; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 51 year-old patient received bnt162b2 (BNT162B2), administered in arm left, administration date 07Jan2021 16:30 (Lot number: EL3246) at the age of 51 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "TIA" (unspecified if ongoing), notes: history of TIAs, occasional once a month migraines; "Migraine" (unspecified if ongoing), notes: history of TIAs, occasional once a month migraines. The patient took concomitant medications. Past drug history included: Flexeril, reaction(s): "Drug allergy", notes: Flexeril, developed a rash, that's it.; Flexeril, reaction(s): "Rash", notes: Flexeril, developed a rash, that's it. Vaccination history included: Bnt162b2 (Dose number=1, Lot number: EK5730, Administration time: 08:00 AM, Vaccine location=Right arm), administration date: 18Dec2020, when the patient was 51 years old, for Covid-19 immunisation. The following information was reported: MIGRAINE (non-serious) with onset 25Jan2021 19:00, outcome "not recovered", described as "migraines". The event "migraines" was evaluated at the physician office visit. Therapeutic measures were taken as a result of migraine.  Additional information: The patient had no other vaccine in four weeks. The patient had no other medications in two weeks. Migraines started January 26th, increased to 6-7 times a week in early February, had not decreased since though the patient tried multiple preventive medications. Had to go on medical leave from work, seeing a neurologist and still trying to get migraines under control. For adverse event the patient tried different abortive and preventive meds. The patient had no covid prior vaccination. The patient had not tested covid post vaccination.  No follow-up attempts are possible. No further information is expected.
I had a lot of fatigue with a headache, sore throat and mild cold symptoms. I also had a mild cough. I contacted my doctor on the day I got the positive test results. She started me on PAXLOVID which I started on the 17th since my daughter was positive for COVID-19 and I am considered high. My symptoms remained mild. I had a low-grade fever. I continued to have mild symptoms until February 22, 2023. For 12 days I thought I had completely recovered even though I continued to have positive antigen test. I believe that I had a rebound case started on March 087, 2023. The symptoms were worse. I completely lost my taste and smell and I felt very fatigued. I never had a fever this time. I am still having symptoms like when they peaked on March 11, 2023. I do have some trouble breathing when I lie down. I have an appointment for Thursday with my primary care provider. I also had a yeast infection during this time which started around March 01, 2023. I think I still have it. I treated with MONISTAT, and it seemed to get better but now feels like it's worse.
3 INDIVIDUALS WERE ADMINISTERED EXPIRED JANSSEN COVID-19 VACCINE; This spontaneous report received from a physician concerned multiple patients.  No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1821286 expiry: 21-OCT-2021) dose was not reported, administered on 11-JAN-2022 for prophylactic vaccination. No concomitant medications were reported. On 11-JAN-2022, the patient experienced 3 individuals were administered expired janssen covid-19 vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of 3 individuals were administered expired janssen covid-19 vaccine was not reported. This report was non-serious.
first dose of Modern vaccine on March 1st and had severe reaction. Pt. states that she was temporarily paralized on left side, droopyness in the face on the left side, and now having a vision problem from vaccine. Pt. states that she was taken to the ER on March 1st. Pt. states that all of these reaction happened within 15 minutes of administration of vaccine. Pt. denies any px during today's visit. No additional questions or concerns at this time. . Patient reports she does have a follow-up with an ophthalmologist.  It is thought she may have had a blood clot in her eye that has led to vision damage.  Patient reports she was seen in the emergency room the same day she received the vaccine.  Adverse reaction started within 15 minutes.
I started chills; Shaking; headache; running 100.9 fever; This case was reported by a consumer via call center representative and described the occurrence of chills in a 62-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of chills (received 1st dose on unknown date, refer case US2019AMR218017).   On 1st December 2019, the patient received the 2nd dose of Shingrix. In December 2019, less than a day after receiving Shingrix, the patient experienced chills, tremor, headache and fever. The patient was treated with paracetamol (Tylenol). Rechallenge with Shingrix was positive. On an unknown date, the outcome of the chills, tremor, headache and fever were unknown.   It was unknown if the reporter considered the chills, tremor, headache and fever to be related to Shingrix.  Additional case details were reported as follows: The patient received Shingrix and started chills, shaking, headache, and running 100.9 fever.  The patient taken Tylenol, water and was staying in bed.  The reporter asked how long this these symptoms last.
Systemic: Exhaustion / Lethargy-Mild, Systemic: Weakness-Mild, Additional Details: patient informed pharmacy she has been feeling tired and soreness in the arm since getting the vaccine. has seen the doctor and used ibuprofen. Will continue to follow up with md.
This spontaneous report was received from a nurse practitioner via a company representative and refers to a 14 year old male patient. There was no information about the patient's pertinent medical history or medical history and drug reactions or allergies provided. Concomitant therapies included VAQTA. On 21-JUL-2016, the patient was vaccinated with a dose of GARDASIL 9 (exact dose and anatomical location were not reported, lot # M005714, expiry date: 03-OCT-2017) intramuscularly. On an unknown date in 2016, the patient experienced syncope and fainted. There was no treatment for the adverse event given. The patient did not seek medical attention. The outcome of syncope was reported as recovered/resolved on an unknown date in 2016. The relatedness between the event and GARDASIL 9 was not reported. Additional information has been requested.
Started out as strong flu-like symptoms for several days starting about 54hrs after first Pfizer injection 5/26.  Fever 101+, body termperature regulation out of whack (intense chills or sweating) body aches and soreness intense headaches and sharp pains in head.  Aceteminophin and Ibuprofen alternated and symptoms would subside for a couple hours at a time.   Into the second week still had more mild flu-like symptoms that have persisted to today, 18 days after shot.  These include headahce, low-grade fever (99-100), continuous tiredness and fatigue, strong aches in lower back, and occasional sharp pains in head, aching behind eyes and occasional chest pain.
Approx 2 wks after 2nd vaccine head started itching, especially after showering. Hair loss also started to occur.  Itching/hair loss progressively increased as days passed. After scratching, skin would welt/hive lasting ~60mins. Intensity increases when body temperatures rise. Welts/hives appear primarily on arms,legs,stomach,back,neck. After several wks of ruling out any new foods/lotions etc, scheduled appt with dermatologist. She confirmed I now have an autoimmune called Dermatographia(aka skin writing) & that this is a known side effect since being vaccinated. Prescribed Zyrtec & Hydroxyzine for 6 wks. Not sure if this is going to be a chronic for me or not. At this time still have Dermatographia.
Patient did not feel well after receiving vaccine. She was seated. She was alert but said she did not feel like she could talk. She was able to respond to commands. 911 was called immediately as a precautions and paramedics arrived after about 7 minutes.
Terrible pain in injection shot with very large lump and red, it itched alot. Breathing a little harder like a chest cold. Ached all over and felt quizze. This all started during the night after shot. Felt fine when had shot at facility.
pt recvd vax; pt exp chills; fever & purple colored rash (pruitic) 20 hrs after vax;had also been taking septra x 10 days;
I had sore arm right away, chills, fever, headache, increased heartrate and breathing, chest tightness, loss of taste and smell, itchy hands and feet. Advised to take Benadryl and hopefully will go away in a few days. I did not take Benadryl. I just waited it out. I currently still can't taste or smell but everything else seems to have resolved after 3 or 4 days.
2ml of normal saline was used to reconstitute the vaccine instead of the 1.8ml. No adverse effects identified.
This spontaneous report as received from a nurse practitioner refers to a 12 month old patient of unknown gender. No information on patient's medical history or concurrent conditions was provided. On 14-JAN-2015, the patient was vaccinated with a dose of PEDVAX HIB lot # K008874 (dose, strength, route of administration and expiration date were not reported) which had temperature excursion. No information on patient's concomitant medication was provided. This is one of several reports from the same reporter. Additional information has been requested.
Itching, redness, and soreness around injection site on 07/26/19 the day after administered at our office. The patient was advised to apply an Ice Pack and Cortisone Cream. She then contacted our office on 08/01/19 to notify us that her arm had became swollen and red all the way down to her wrist with extreme pain to the point where she could not move the arm. She then started with nausea and vomiting and stated that from 07/25/19 to 07/30/19 she was bedridden. She started feeling better on 07/31/19 but has not came into the office for a visit.
Mild confusion; Anaemia; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (Mild confusion) and ANAEMIA (Anaemia) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CONFUSIONAL STATE (Mild confusion) and ANAEMIA (Anaemia). At the time of the report, CONFUSIONAL STATE (Mild confusion) and ANAEMIA (Anaemia) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were mentioned. No treatment details were reported.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: Additional information received on 29 June 2021 Included event Anemia and primary reporter contact details updated.
36 hours after DTaP (LA), IPV (LA), MMR (RA) left arm swollen red from last night, worse today. Mom has been applying ice - no improvement. Suggest giving Tylenol or Motrin.
05/13/2022 I had vaccination. On 07/21/2022 I started to experience a sore throat. I have a history of low sodium which I was worried as it can be dangerous. I went to the doctor for my brain fog the blood panel showed my sodium levels were fine. He contributed the brain fog to COVID-19. I was not put on any medication.
This case was reported by a healthcare professional and described the occurrence of burning eyes (eye irritation) in a 39-year-old female subject who was accidentally exposed to ROTARIX while preparing the vaccine for administration. Concurrent medical conditions included contact lenses. Concurrent medications included CONCERTA. On 27 October 2011 at 11:45 the subject accidentally was exposed a dose of ROTARIX (intraocular) while preparing drug for administration. On 27 October 2011, less than one day after accidental exposure to eye with ROTARIX, the subject experienced burning eyes (eye irritation). The subject inadvertently got ROTARIX vaccine or diluent alone in her eye when she was mixing the vaccine. The subject stated that the eye burned. She removed the contact lens and flushed the eye with water for at least 5 minutes. At the time of reporting, the burning eyes (eye irritation) was improved, but the eye was still irritated.
Major Seizure; This is a spontaneous report from a contactable Consumer or other non-HCP (parent). An 18-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: FE3590, Expiration date: Unknown), via an unspecified route of administration in right arm on 22Oct2021 at 14:00 (at the age of 18-year-old), as DOSE 3 (BOOSTER), SINGLE for COVID-19 immunization. The patient medical history included allergy. There were no concomitant medications. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccine within 4 weeks prior to the COVID-19 vaccine. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received the past drugs BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL3249, Expiration date: Unknown), via an unspecified route of administration in right arm on 15Jan2021, as dose 1, single and then BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EM9810, Expiration date: Unknown), via an unspecified route of administration in right arm on 05Feb2021, as dose 2, single for COVID-19 immunization. On 28Oct2021 at 07:00, the patient experienced major seizure. The adverse events resulted in doctor or other healthcare professional office, or clinic visit and emergency room or department or urgent care visit. Therapeutic measures were taken as a result of major seizure. The case was reported as non-serious and the event did not result death, Life threatening, Caused/prolonged hospitalization, Disabling/Incapacitating and Congenital anomaly/birth defect. The outcome of the event was unknown at the time of this report.  Follow-up attempts are completed. No further information is expected.
Patient described an itchy rash that started about a week after getting vaccination. The rash presented as red, raised bumps on his arms, neck, mid back, and forehead/scalp area. It has lasted over a month, he went to dermatologist to get steroid creams. He says they seem to be getting better.
pt recv vax;devel generalized rash & itching;to MD who said sx were contact dermatitis;recv 2nd & 3rd doses w/ no problems;lab eval revealed anti-HBs 3.5 RU;4th dose given on 31mar94;
Initial and follow up information has been received from a medical assistant concerning a 27 year old female teacher/administrator patient who on 27-JUN-2007 at 02:50 PM (previously reported as 26-JUN-2007) was vaccinated IM into left deltoid with a first dose of Gardasil lot #658222/0927U and on 27-AUG-2007 received the second dose of Gardasil. The reporter reported that the patient felt lightheaded, nauseated and dizzy for 15 minutes after the second vaccination on 27-AUG-2007. She felt fine after lying down for 15 minutes. In follow up it was reported that the nurse went back to check on the patient after 15 minute later and "she said she was feeling fine and wanted to go to work". She did not have any problem after receiving her first dose of Gardasil. On 27-AUG-2007, the patient recovered. Additional information has been requested. Additional information is not expected.
Swelling at the injection site began about 24 hours after the injection and then it worsened over the successive 24 hours. On exam today, there is an area of warm, indurated erythema, 5 cm X 8 cm, tender. Motrin given and advised to apply ice and re-examine in 2-3 days.
Patient began having a small red bumps appear on the face shortly after receiving the flu and covid vaccine. Dr. and other staff members attained to the patient immediately with Epi-Pens on hand for possible administration. Patient was looked over, and examined by Dr.  Dr. then decided to have Benadryl 10 mL's administered for the possible adverse reaction. No hives or other rashes on trunk, arms, or back were noted. No difficulty breathing, elevated heartrate, or pharyngeal erythema present.